AC Immune (ACIU) Free Cash Flow (QoQ) (2016 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | AC Immune | 325.88 Mn | 211.53 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 10.66% |
| Sep 30, 2025 | -21.76% |
| Jun 30, 2025 | 9.51% |
| Mar 31, 2025 | -407.25% |
| Dec 31, 2024 | 142.63% |
| Sep 30, 2024 | -119.95% |
| Jun 30, 2024 | 5,442.03% |
| Mar 31, 2024 | 107.98% |
| Dec 31, 2023 | -22.35% |
| Sep 30, 2023 | 4.33% |
| Jun 30, 2023 | 13.04% |
| Mar 31, 2023 | 11.03% |
| Dec 31, 2022 | -45.22% |
| Sep 30, 2022 | 29.37% |
| Jun 30, 2022 | 19.63% |
| Mar 31, 2022 | -3.03% |
| Dec 31, 2021 | -55.74% |
| Sep 30, 2021 | 9.66% |
| Jun 30, 2021 | 7.76% |
| Mar 31, 2021 | 23.52% |
| Dec 31, 2020 | -43.55% |
| Sep 30, 2020 | -10.83% |
| Jun 30, 2020 | -53.57% |
| Mar 31, 2020 | -1.57% |
| Dec 31, 2019 | -157.39% |
| Sep 30, 2019 | 202.77% |
| Jun 30, 2019 | -124.49% |
| Mar 31, 2019 | 544.95% |
| Dec 31, 2018 | -26.16% |
| Sep 30, 2018 | -74.11% |
| Jun 30, 2018 | 47.20% |
| Mar 31, 2018 | -100.05% |
| Dec 31, 2017 | 197.51% |
| Sep 30, 2017 | -336,812.33% |
| Jun 30, 2017 | 26.93% |
| Mar 31, 2017 | -32.04% |
| Dec 31, 2016 | -193.70% |
| Sep 30, 2016 | 1,420.61% |
| Jun 30, 2016 | 107.94% |
| Mar 31, 2016 | -22.95% |